133 results
Page 3 of 7
8-K/A
EX-99.3
i2w wznu8c927uj
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
n0sevynbi
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.4
yna7x
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
savat5wqtpk9owau
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
3kn 9gwqjd
28 Aug 20
Prospectus supplement
4:31pm
425
f62zcf
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
yqd15ny0af2rqavu3w
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.1
yeh1zmr6wvs9erq
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
ckc5ghw jk
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
z9yv3p4ji60ug
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
cl0y75afc6 hw2o4bb00
24 Jun 20
Business combination disclosure
4:03pm
425
nm2mz40qcai2603q
22 Jun 20
Business combination disclosure
5:30pm